Johnson & Johnson (JNJ) Treasury Shares (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Treasury Shares came in at $76.3 billion in Q1 2026, little changed year-on-year from $75.9 billion in Q1 2025, and up 0.85% quarter-over-quarter from $75.6 billion in Q4 2025.

Johnson & Johnson (JNJ) Treasury Shares (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Treasury Shares across 18 years of filings, most recently posting $76.3 billion for Q1 2026.

  • Treasury Shares for Q1 2026 came in at $76.3 billion, changed 0.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $76.3 billion (changed 0.47% YoY), and the FY2025 annual result was $75.6 billion, changed 0.07% from the prior year.
  • Treasury Shares came in at $76.3 billion for Q1 2026 at Johnson & Johnson, up from $75.6 billion in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $714.2 million in Q1 2025 to a low of $490.5 million in Q2 2022.
  • The 5-year median for Treasury Shares is $712.6 million (2023), against an average of $631.5 million.
  • Across the five-year window, Treasury Shares jumped 83.85% in 2023 and decreased 0.07% in 2025, its largest moves.
  • Johnson & Johnson's Treasury Shares stood at $41.1 billion in 2022, then surged by 83.89% to $75.7 billion in 2023, then increased by 0.02% to $75.7 billion in 2024, then declined by 0.07% to $75.6 billion in 2025, then increased by 0.85% to $76.3 billion in 2026.
  • The last three Treasury Shares figures came in at $76.3 billion (Q1 2026), $75.6 billion (Q4 2025), and $75.9 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 3.01 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 713.26 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 77.08 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 1.11 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 3.94 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 881.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -47.00 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 76.26 Bn
Mar 29, 2026 713.26 Mn
Mar 29, 2026 76.26 Bn
Mar 29, 2026 713.26 Mn
Dec 28, 2025 75.62 Bn
Dec 28, 2025 711.90 Mn
Dec 28, 2025 711.90 Mn
Dec 28, 2025 75.62 Bn
Sep 28, 2025 713.65 Mn
Sep 28, 2025 713.65 Mn
Sep 28, 2025 75.89 Bn
Sep 28, 2025 75.89 Bn
Jun 29, 2025 713.06 Mn
Jun 29, 2025 75.71 Bn
Jun 29, 2025 75.71 Bn
Jun 29, 2025 713.06 Mn
Mar 30, 2025 75.91 Bn
Mar 30, 2025 714.22 Mn
Mar 30, 2025 714.22 Mn
Mar 30, 2025 75.91 Bn